The SURMOUNT-1 Trial (Mounjaro/Zepbound) In the landmark SURMOUNT-1 trial, participants taking the highest dose of tirzepatide (15 mg) lost an average of 22.5% of their body weight over 72 weeks
When retatrutide activates GLP-1 receptors in the brain, it reduces appetite and increases feelings of fullness
,
This decline is one reason why our skin loses elasticity and why our hair may start to thin and lose its vitality over time
If you have been researching your options, this ReadyRx review covers exactly what it is, how it works, what it costs, and whether it is worth your time and money in 2026
Theyre easy to add to your diet in dishes like balsamic roasted beets, hummus, fries, and salads, among others